Lipocine LPCN
NASDAQ LPCN
$2.09 +0.00 (+0.00%)
As of: Aug 21, 2026 · 3:59 PM EDT

Lipocine (LPCN) Amortizatization of Intangibles (2015 - 2025)

Lipocine's (LPCN) quarterly Amortizatization of Intangibles came in at $33908.0 in Q3 2025, down 79.83% YoY from $168145.0 in Q3 2024, and down 1.48% on a QoQ basis from $34416.0 in Q2 2025.

Lipocine (LPCN) Amortizatization of Intangibles (2015 - 2025) Analysis & Trends

Lipocine (LPCN) has 11 years of Amortizatization of Intangibles data on file, last reported at $33908.0 in Q3 2025.

  • Quarterly Amortizatization of Intangibles fell 79.83% year-over-year to $33908.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $245108.0 (down 68.65% YoY) and the FY2024 annual result came in at $697865.0, down 26.74% from the prior year.
  • Amortizatization of Intangibles retreated to $33908.0 in Q3 2025, from $34416.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $254215.0 in Q1 2023 to a low of -$156618.0 in Q4 2021.
  • A 5-year average of $72816.8 and a median of $58209.0 in 2025 frame the typical range for Amortizatization of Intangibles.
  • Annual changes were most pronounced in 2021 — Amortizatization of Intangibles slumped 805.45% — and 2023, when it jumped 806.14%.
  • Tracing LPCN's Amortizatization of Intangibles over 5 years: stood at -$156618.0 in 2021, then jumped by 201.54% to $159036.0 in 2022, then advanced by 27.37% to $202559.0 in 2023, then sank by 41.46% to $118575.0 in 2024, then tumbled by 71.4% to $33908.0 in 2025.
  • The last three Amortizatization of Intangibles figures came in at $33908.0 (Q3 2025), $34416.0 (Q2 2025), and $58209.0 (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 678,000.00
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Lipocine 11.15 Mn -12.76 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2025 33,908.00
Sep 30, 2025 33,908.00
Jun 30, 2025 34,416.00
Jun 30, 2025 34,416.00
Mar 31, 2025 58,209.00
Mar 31, 2025 58,209.00
Dec 31, 2024 118,575.00
Dec 31, 2024 118,575.00
Sep 30, 2024 168,145.00
Sep 30, 2024 168,145.00
Jun 30, 2024 196,249.00
Jun 30, 2024 196,249.00
Mar 31, 2024 214,896.00
Mar 31, 2024 214,896.00
Dec 31, 2023 202,559.00
Dec 31, 2023 202,559.00
Sep 30, 2023 241,667.00
Sep 30, 2023 241,667.00
Jun 30, 2023 254,210.00
Jun 30, 2023 254,210.00